Abstract:The human microbiota is an aggregate of microorganisms residing in the human body, mostly in the gastrointestinal tract (GIT). Our gut microbiota evolves with us and plays a pivotal role in human health and disease. In recent years, the microbiota has gained increasing attention due to its impact on host metabolism, physiology, and immune system development, but also because the perturbation of the microbiota may result in a number of diseases. The gut microbiota may be linked to malignancies such as gastric cancer and colorectal cancer. It may also be linked to disorders such as nonalcoholic fatty liver disease (NAFLD); obesity and diabetes, which are characterized as “lifestyle diseases” of the industrialized world; coronary heart disease; and neurological disorders. Although the revolution in molecular technologies has provided us with the necessary tools to study the gut microbiota more accurately, we need to elucidate the relationships between the gut microbiota and several human pathologies more precisely, as understanding the impact that the microbiota plays in various diseases is fundamental for the development of novel therapeutic strategies. Therefore, the aim of this review is to provide the reader with an updated overview of the importance of the gut microbiota for human health and the potential to manipulate gut microbial composition for purposes such as the treatment of antibiotic-resistant Clostridium difficile (C. difficile) infections. The concept of altering the gut community by microbial intervention in an effort to improve health is currently in its infancy. However, the therapeutic implications appear to be very great. Thus, the removal of harmful organisms and the enrichment of beneficial microbes may protect our health, and such efforts will pave the way for the development of more rational treatment options in the future.

In volve ment of Patched ( PTCH ) Gene in Gorlin Syn drome and Re lated Dis or ders : Three Fam ily Cases

Bacterial‐fungal interactions and their impact on microbial pathogenesis

EVALUATOR: An Automated Tool for Service Selection

Interactions between Candida albicans and the resident microbiota

Complex Predicates and Logics for Properties and Relations

Microbial interactions and the homeostasis of the gut microbiome: the role of Bifidobacterium

Determination of organophosphorus pesticides in water by solid-phase microextraction.

Diet-Microbe-Host Interactions That Affect Gut Mucosal Integrity and Infection Resistance

The Influence of the Gut Microbiota on Host Health: A Focus on the Gut–Lung Axis and Therapeutic Approaches

Oral microbiota and metabolites: key players in oral health and disorder, and microbiota-based therapies

Cross-kingdom interaction between Candida albicans and oral bacteria

Interconnections between the Oral and Gut Microbiomes: Reversal of Microbial Dysbiosis and the Balance between Systemic Health and Disease

Microbiota in Health and Disease-Potential Clinical Applications

The Impact of Intraspecies and Interspecies Bacterial Interactions on Disease Outcome

Modulation of Gut Microbiota in Pathological States

Mucosal Immunity to Gut Fungi in Health and Inflammatory Bowel Disease

Commensal inter-bacterial interactions shaping the microbiota

Human gut microbiota in health and disease: Unveiling the relationship

Tipping the Balance: C. albicans Adaptation in Polymicrobial Environments

The microbiota: a crucial mediator in gut homeostasis and colonization resistance

The effect of different levels of larval intake on the output of eggs by Ostertagia circumcincta in lambs.